Plunkett's Biotech & Genetics Industry Trends & Statistics 2012: A Summary Version of Plunkett's Biotech & Genetics Industry Almanac 2012


September 1, 2011
SKU: PLK6505296
License type:
Plunkett's Biotech & Genetics Industry Trends & Statistics  2012: A Summary Version of Plunkett's Biotech & Genetics Industry Almanac 2012

  enlarge
This carefully researched report, an excerpt from Plunkett's Biotech & Genetics Industry Almanac 2012, will be your ready-reference guide to the Biotechnology and Genetics Industry. This summary includes our analysis of major trends as well as statistical tables-a tool for strategic planning, business development or industry analysis. Trends analyzed range from the convergence of nanotechnology and biotechnology, to the evolution of breakthrough new drug delivery systems, to the abounding ethical issues connected with biotech. Topics include: biotechnology funding and investments, FDA, gene therapies, personalized medicine, systems biology, clinical trials, stem cells, therapeutic cloning, nanotechnology, agricultural biotechnology (GM seeds), drug delivery systems and ethical issues.



 
Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!